English

Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESC Congress 2019

Report this content

Press release

Free for publication on August 29, 2019 at 3.30 pm (CEST +1)

Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESC Congress 2019

Oulu, Finland, August 29, 2019 – Bittium exhibits its cardiac monitoring products and solutions at European Society of Cardiology (ESC) Congress 2019 in Paris, France on August 31 – September 4, 2019. ESC Congress is the world's largest conference in cardiovascular medicine organized by the European Society of Cardiology.

At the event Bittium will showcase solutions designed for long-term cardiac measuring and analyzing, and monitoring patients remotely.  The products to be presented at Bittium’s stand F515  are the waterproof Bittium Faros™ ECG device and  waterproof Bittium FastFix™ patch electrode for long-term ECG measurement, Bittium HolterPlus™ a web based remote cardiac monitoring solution, Bittium Cardiac Navigator™ software for accurate analyzing of long-term Holter ECG recordings and Bittium Cardiac Explorer™ software for analyzing cardiac event based ECG recordings.

Products and solutions exhibited at the event are:

  • Bittium Faros is a versatile waterproof ECG device that is used for early detection of cardiac abnormalities in everyday life. Bittium Faros is ultra-small and lightweight, which enables precise full disclosure ECG measurements for long-term Holtering, cardiac event monitoring, mobile cardiac telemetry and assessing autonomic nervous system functions.
    Bittium Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms on the Bittium Faros device are used for event recording and cardiac event monitoring. Bittium’s solutions enable the earlier discharge of patients and the ability to react to detected arrhythmias faster.
  • Bittium HolterPlus is a web based remote cardiac monitoring solution, consisting of a Bittium Faros ECG device and Bittium HolterPlus mobile application integrated into a secure smart device. Bittium HolterPlus enables remote monitoring and earlier discharge of the patient, and allows the ECG measurement data of the remotely monitored patient to be wirelessly transferred securely from the monitoring device to the medical remote diagnostics service platform. From the platform the ECG recording can be downloaded to a cardiologist for diagnosis and the diagnosis will be uploaded for the treating physician for further patient care.    
  • Bittium Cardiac Navigator is a completely new type of solution for the analysis of clinical Holter ECG recordings. Its user-friendly and informative data presentation and intuitive analysis tools make the software efficient and easy to use when analyzing multiple days of ECG recordings. Bittium Cardiac Navigator is designed for scanning longer measurements efficiently in a shorter time and thus speeding up the final diagnosis.
  • Bittium Cardiac Explorer offers a quick and flexible way of working with event-based ECG arrhythmia analysis. The biggest benefits of the software are having full disclosure ECG always available, full access to the events identified by the device, total control on the reporting content and the ability to analyze an unlimited amount of measurement data.

More information on the offering: https://www.bittium.com/medical

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507

Distribution:
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2018 were EUR 62.8 million and operating profit was EUR 2.8 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Subscribe